(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
0.64% $ 7.07
Live Chart Being Loaded With Signals
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology...
Stats | |
---|---|
Tagesvolumen | 14 150.00 |
Durchschnittsvolumen | 9 630.00 |
Marktkapitalisierung | 2.71B |
EPS | $0 ( 2024-03-01 ) |
Nächstes Ertragsdatum | ( $0 ) 2024-05-23 |
Last Dividend | $0.117 ( 2023-08-25 ) |
Next Dividend | $0 ( N/A ) |
P/E | 20.79 |
ATR14 | $0.0430 (0.61%) |
Elekta AB (publ) Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Elekta AB (publ) Finanzdaten
Annual | 2023 |
Umsatz: | $16.87B |
Bruttogewinn: | $6.35B (37.64 %) |
EPS: | $2.47 |
FY | 2023 |
Umsatz: | $16.87B |
Bruttogewinn: | $6.35B (37.64 %) |
EPS: | $2.47 |
FY | 2022 |
Umsatz: | $14.55B |
Bruttogewinn: | $5.44B (37.37 %) |
EPS: | $3.02 |
FY | 2021 |
Umsatz: | $13.76B |
Bruttogewinn: | $5.61B (40.76 %) |
EPS: | $3.28 |
Financial Reports:
No articles found.
Elekta AB (publ) Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.118 (N/A) |
$0 (N/A) |
$0.118 (N/A) |
$0 (N/A) |
$0.117 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.305 | 2013-09-04 |
Last Dividend | $0.117 | 2023-08-25 |
Next Dividend | $0 | N/A |
Payout Date | 2023-09-15 | |
Next Payout Date | N/A | |
# dividends | 18 | -- |
Total Paid Out | $1.985 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.93 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.56 | |
Div. Directional Score | 9.15 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RMYHY | Ex Dividend Junior | 2023-09-05 | Semi-Annually | 0 | 0.00% | |
EVSBY | Ex Dividend Knight | 2023-05-24 | Annually | 0 | 0.00% | |
WJRYF | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
LNSTY | Ex Dividend Knight | 2023-08-17 | Semi-Annually | 0 | 0.00% | |
CGEMY | Ex Dividend Knight | 2023-05-25 | Annually | 0 | 0.00% | |
SLVYY | Ex Dividend Knight | 2023-05-15 | Semi-Annually | 0 | 0.00% | |
GBLBY | Ex Dividend Junior | 2023-05-11 | Annually | 0 | 0.00% | |
ACCYY | Ex Dividend Knight | 2023-05-23 | Sporadic | 0 | 0.00% | |
NASB | Ex Dividend Junior | 2023-09-15 | Quarterly | 0 | 0.00% | |
CNLTP | Ex Dividend Knight | 2023-07-07 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0786 | 1.500 | 8.43 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0466 | 1.200 | 8.45 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.141 | 1.500 | 9.54 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.640 | -1.000 | 3.60 | -3.60 | [0 - 1] |
currentRatioTTM | 1.095 | 0.800 | 9.53 | 7.62 | [1 - 3] |
quickRatioTTM | 0.822 | 0.800 | 9.87 | 7.90 | [0.8 - 2.5] |
cashRatioTTM | 0.181 | 1.500 | -0.104 | -0.156 | [0.2 - 2] |
debtRatioTTM | 0.198 | -1.500 | 6.70 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 6.24 | 1.000 | 8.80 | 8.80 | [3 - 30] |
operatingCashFlowPerShareTTM | 8.21 | 2.00 | 7.26 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.98 | 2.00 | 8.01 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.593 | -1.500 | 7.63 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.377 | 1.000 | 7.04 | 7.04 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.129 | 1.000 | 9.41 | 9.41 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.516 | 1.000 | 8.25 | 8.25 | [0.2 - 2] |
assetTurnoverTTM | 0.593 | 0.800 | 9.38 | 7.50 | [0.5 - 2] |
Total Score | 12.75 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 20.39 | 1.000 | 8.04 | 0 | [1 - 100] |
returnOnEquityTTM | 0.141 | 2.50 | 9.70 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.98 | 2.00 | 8.67 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.0283 | 1.500 | 9.29 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 8.21 | 2.00 | 7.26 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.640 | 1.500 | 3.60 | -3.60 | [0 - 1] |
pegRatioTTM | -0.104 | 1.500 | -4.02 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.172 | 1.000 | 8.20 | 0 | [0.1 - 0.5] |
Total Score | 5.56 |
Elekta AB (publ)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.